Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.

Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, Ling A, Eisenhofer G, Adams KT, Pacak K.

J Nucl Med. 2007 Oct;48(10):1599-606. Epub 2007 Sep 14.

2.

6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.

Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP.

J Clin Endocrinol Metab. 2009 Oct;94(10):3922-30. doi: 10.1210/jc.2009-1054. Epub 2009 Jul 21.

PMID:
19622618
3.

Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.

Rischke HC, Benz MR, Wild D, Mix M, Dumont RA, Campbell D, Seufert J, Wiech T, Rössler J, Weber WA, Neumann HP.

J Nucl Med. 2012 Sep;53(9):1352-8. doi: 10.2967/jnumed.111.101303. Epub 2012 Jul 26.

4.

Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.

Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, Eisenhofer G, Martiniova L, Adams KT, Pacak K.

J Clin Endocrinol Metab. 2009 Dec;94(12):4757-67. doi: 10.1210/jc.2009-1248. Epub 2009 Oct 28.

5.

Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas?

Hentschel M, Rottenburger C, Boedeker CC, Neumann HP, Brink I.

Clin Nucl Med. 2012 Feb;37(2):e24-9. doi: 10.1097/RLU.0b013e318238f550.

PMID:
22228360
6.

(18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.

Magnaldi S, Mayerhoefer ME, Khameneh A, Schuetz M, Javor D, Mitterhauser M, Dudczak R, Hacker M, Karanikas G.

Anticancer Res. 2014 Feb;34(2):791-5.

PMID:
24511014
7.

6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.

Fottner C, Helisch A, Anlauf M, Rossmann H, Musholt TJ, Kreft A, Schadmand-Fischer S, Bartenstein P, Lackner KJ, Klöppel G, Schreckenberger M, Weber MM.

J Clin Endocrinol Metab. 2010 Jun;95(6):2800-10. doi: 10.1210/jc.2009-2352. Epub 2010 Apr 6.

PMID:
20371665
8.

A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma.

Kroiss A, Putzer D, Frech A, Decristoforo C, Uprimny C, Gasser RW, Shulkin BL, Url C, Widmann G, Prommegger R, Sprinzl GM, Fraedrich G, Virgolini IJ.

Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1800-8. doi: 10.1007/s00259-013-2548-y. Epub 2013 Sep 27.

PMID:
24072345
9.

Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.

Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King KS, Rao JU, Wesley RA, Adams KT, Pacak K.

J Natl Cancer Inst. 2012 May 2;104(9):700-8. doi: 10.1093/jnci/djs188. Epub 2012 Apr 18.

10.

18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.

Imani F, Agopian VG, Auerbach MS, Walter MA, Imani F, Benz MR, Dumont RA, Lai CK, Czernin JG, Yeh MW.

J Nucl Med. 2009 Apr;50(4):513-9. doi: 10.2967/jnumed.108.058396. Epub 2009 Mar 16.

11.

Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.

Moreau A, Giraudet AL, Kryza D, Borson-Chazot F, Bournaud C, Mognetti T, Lifante JC, Combemale P, Giammarile F, Houzard C.

Nucl Med Commun. 2017 Sep;38(9):771-779. doi: 10.1097/MNM.0000000000000708.

PMID:
28704339
12.

Role of (18) F-FDOPA PET/CT imaging in endocrinology.

Santhanam P, Taïeb D.

Clin Endocrinol (Oxf). 2014 Dec;81(6):789-98. doi: 10.1111/cen.12566. Epub 2014 Sep 1. Review.

PMID:
25056984
13.

Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.

Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, Galli G, Fanti S, Giordano A.

Nucl Med Commun. 2011 Jul;32(7):575-82. doi: 10.1097/MNM.0b013e328345a340.

PMID:
21471850
14.

Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.

Martiniova L, Cleary S, Lai EW, Kiesewetter DO, Seidel J, Dawson LF, Phillips JK, Thomasson D, Chen X, Eisenhofer G, Powers JF, Kvetnansky R, Pacak K.

Nucl Med Biol. 2012 Feb;39(2):215-26. doi: 10.1016/j.nucmedbio.2011.07.007. Epub 2011 Sep 29.

15.

Role of 18F-DOPA PET/CT in diagnosis and follow-up of adrenal and extra-adrenal paragangliomas.

Bacca A, Chiacchio S, Zampa V, Carrara D, Duce V, Congregati C, Simi P, Taddei S, Materazzi G, Volterrani D, Mariani G, Bernini G.

Clin Nucl Med. 2014 Jan;39(1):14-20. doi: 10.1097/RLU.0000000000000242.

PMID:
24300347
16.

18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes.

Marzola MC, Chondrogiannis S, Grassetto G, Rampin L, Maffione AM, Ferretti A, Opocher G, Schiavi F, Colletti PM, Rubello D.

Clin Nucl Med. 2014 Jan;39(1):e53-8. doi: 10.1097/RLU.0b013e31829aface.

PMID:
23856824
17.

18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.

Blanchet EM, Taieb D, Millo C, Martucci V, Chen CC, Merino M, Herscovitch P, Pacak K.

J Nucl Med. 2015 Dec;56(12):1849-54. doi: 10.2967/jnumed.115.159061. Epub 2015 Sep 10.

18.

Compared to 123I-MIBG SPECT/CT, 18F-DOPA PET/CT provides accurate tumor extent in patients with extra-adrenal paraganglioma.

Kroiss AS, Uprimny C, Shulkin BL, Frech A, Tilg H, Gasser RW, Sprinzl GM, Gruber L, Thomé C, Plangger C, Url C, Fraedrich G, Virgolini IJ.

Ann Nucl Med. 2017 Jun;31(5):357-365. doi: 10.1007/s12149-017-1162-7. Epub 2017 Mar 27.

PMID:
28349331
19.

Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..

Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, Reincke M, Moser E, Neumann HP.

Radiology. 2002 Feb;222(2):507-12.

PMID:
11818620
20.

Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.

Gabriel S, Blanchet EM, Sebag F, Chen CC, Fakhry N, Deveze A, Barlier A, Morange I, Pacak K, Taïeb D.

Clin Endocrinol (Oxf). 2013 Aug;79(2):170-7. doi: 10.1111/cen.12126. Epub 2013 May 6.

Supplemental Content

Support Center